Associated Papers
ARLTS1 polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis.
Jiang Y et al.
Hereditary Cancer in Clinical Practice, 2017
Exome sequencing reveals comprehensive genomic alterations across eight cancer cell lines.
Chang H et al.
Plos One, 2011
21701589 (PubMed )
Supplement: pone.0021097.s002.xls › a549_f40r3
Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.
Siltanen S et al.
Plos One, 2011
Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
Bartsch DK et al.
Clinical Genetics, 2010
Association of the ARLTS1 variants with familial ovarian cancer risk in China.
Yang XY et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society, 2009
ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer.
Siltanen S et al.
European Journal of Human Genetics : Ejhg, 2008
Association of the ARLTS1 Cys148Arg variant with sporadic and familial colorectal cancer.
Castellví-Bel S et al.
Carcinogenesis, 2007
No association of ARLTS1 polymorphisms and risk for familial chronic lymphocytic leukaemia.
Ng D et al.
British Journal of Haematology, 2007
ARLTS1 polymorphisms and basal cell carcinoma of the skin.
Li X et al.
Hereditary Cancer in Clinical Practice, 2007
Relationship between ARLTS1 polymorphisms and risk of chronic lymphocytic leukemia.
Sellick GS et al.
Leukemia Research, 2006
Association of the ARLTS1 Cys148Arg variant with familial breast cancer risk.
Frank B et al.
International Journal of Cancer, 2006
Familial cancer associated with a polymorphism in ARLTS1.
Sellick GS et al.
The New England Journal of Medicine, 2006
Familial cancer associated with a polymorphism in ARLTS1.
Calin GA et al.
The New England Journal of Medicine, 2005
Select a paper to view details